Zemin Lin

7PUBLICATIONS
10CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 04, 2026
(5R)-5-Hydroxytriptolide (LLDT-8) Ameliorates Experimental Autoimmune Myositis via Suppression of the NLRC5/MHC-I Signaling Pathway.

|Feb 05, 2026
Rebalancing the inflammatory trajectory from inflammatory bowel disease to colitis-associated colorectal cancer via artemisinin-based multitarget therapy.

Shi-Jun He, Mei-Lin Tang, Li Chen

|Feb 02, 2026
From Hit to Lead: Discovery of Novel Selective RIPK1 Inhibitor with Pyridoimidazole Scaffold for the Treatment of Autoimmune Diseases through Phenotypic Screening and Structural Optimization.

Jihong Wan, Xiao-Yu Xiong, Zixiang Geng

|Sep 19, 2024
From Hit to Lead: Discovery of First-In-Class Furanone Glycoside D228 Derived from Chimonanthus salicifolius for the Treatment of Inflammatory Bowel Disease.

Mei-Lin Tang, Xiao-Yu Xiong, Heyanhao Zhang

|Apr 08, 2024
Interplay of IL-17A/IL-17RA signaling with microbial homeostasis in systemic anti-tumoral responses.

Shi-Jun He, Jian-Ping Zuo, Ze-Min Lin

Pageof 2

Frequent Collaborators

3 joint publications

Mei-Lin Tang

2 joint publications

Shijun He

1 joint publications

Yun-Zhi Wang

1 joint publications

Jun Chang